Corline Biomedical (Sweden) Buy Hold or Sell Recommendation
CLBIO Stock | SEK 10.90 0.10 0.91% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Corline Biomedical AB is 'Strong Sell'. Macroaxis provides Corline Biomedical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CLBIO positions. The advice algorithm takes into account all of Corline Biomedical's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Corline Biomedical's buy or sell advice are summarized below:
Real Value 10.11 | Hype Value 10.9 | Market Value 10.9 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Corline Biomedical AB given historical horizon and risk tolerance towards Corline Biomedical. When Macroaxis issues a 'buy' or 'sell' recommendation for Corline Biomedical AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
Corline |
Execute Corline Biomedical Buy or Sell Advice
The Corline recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Corline Biomedical AB. Macroaxis does not own or have any residual interests in Corline Biomedical AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Corline Biomedical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Corline Biomedical Trading Alerts and Improvement Suggestions
Corline Biomedical generated a negative expected return over the last 90 days | |
Corline Biomedical has high likelihood to experience some financial distress in the next 2 years | |
The company reported the revenue of 7.06 M. Net Loss for the year was (6.92 M) with profit before overhead, payroll, taxes, and interest of 9.1 M. | |
Corline Biomedical AB has accumulated about 41.63 M in cash with (4.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.45. | |
Roughly 55.0% of the company shares are held by company insiders |
Corline Biomedical Returns Distribution Density
The distribution of Corline Biomedical's historical returns is an attempt to chart the uncertainty of Corline Biomedical's future price movements. The chart of the probability distribution of Corline Biomedical daily returns describes the distribution of returns around its average expected value. We use Corline Biomedical AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Corline Biomedical returns is essential to provide solid investment advice for Corline Biomedical.
Mean Return | -0.39 | Value At Risk | -4.51 | Potential Upside | 3.82 | Standard Deviation | 2.53 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Corline Biomedical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Corline Biomedical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Corline Biomedical or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Corline Biomedical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Corline stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.39 | |
β | Beta against NYSE Composite | -0.09 | |
σ | Overall volatility | 2.51 | |
Ir | Information ratio | -0.19 |
Corline Biomedical Volatility Alert
Corline Biomedical AB exhibits very low volatility with skewness of 0.12 and kurtosis of -0.43. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Corline Biomedical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Corline Biomedical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Corline Biomedical Fundamentals Vs Peers
Comparing Corline Biomedical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Corline Biomedical's direct or indirect competition across all of the common fundamentals between Corline Biomedical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Corline Biomedical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Corline Biomedical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Corline Biomedical by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Corline Biomedical to competition |
Fundamentals | Corline Biomedical | Peer Average |
Return On Equity | 0.0075 | -0.31 |
Return On Asset | 0.0044 | -0.14 |
Profit Margin | 0.02 % | (1.27) % |
Operating Margin | 0.02 % | (5.51) % |
Current Valuation | 178.43 M | 16.62 B |
Shares Outstanding | 21.49 M | 571.82 M |
Shares Owned By Insiders | 54.88 % | 10.09 % |
Shares Owned By Institutions | 14.21 % | 39.21 % |
Price To Earning | (19.42) X | 28.72 X |
Price To Book | 2.20 X | 9.51 X |
Price To Sales | 6.44 X | 11.42 X |
Revenue | 7.06 M | 9.43 B |
Gross Profit | 9.1 M | 27.38 B |
EBITDA | (6.88 M) | 3.9 B |
Net Income | (6.92 M) | 570.98 M |
Cash And Equivalents | 41.63 M | 2.7 B |
Cash Per Share | 1.45 X | 5.01 X |
Current Ratio | 3.99 X | 2.16 X |
Book Value Per Share | 4.38 X | 1.93 K |
Cash Flow From Operations | (4.83 M) | 971.22 M |
Earnings Per Share | 0.03 X | 3.12 X |
Target Price | 29.0 | |
Number Of Employees | 10 | 18.84 K |
Beta | 0.8 | -0.15 |
Market Capitalization | 203.87 M | 19.03 B |
Total Asset | 101.66 M | 29.47 B |
Net Asset | 101.66 M |
Corline Biomedical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Corline . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Corline Biomedical Buy or Sell Advice
When is the right time to buy or sell Corline Biomedical AB? Buying financial instruments such as Corline Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Corline Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Health Care ETFs Thematic Idea Now
Health Care ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Health Care ETFs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Care ETFs Theme or any other thematic opportunities.
View All Next | Launch |
Check out Corline Biomedical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Corline Stock analysis
When running Corline Biomedical's price analysis, check to measure Corline Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corline Biomedical is operating at the current time. Most of Corline Biomedical's value examination focuses on studying past and present price action to predict the probability of Corline Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corline Biomedical's price. Additionally, you may evaluate how the addition of Corline Biomedical to your portfolios can decrease your overall portfolio volatility.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
CEOs Directory Screen CEOs from public companies around the world |